Corcept Therapeutics Incorporated · NASDAQ:CORT
Mokari Atabak sold 40,000 Corcept Therapeutics Incorporated shares (Form 4)
Traded Jun 15, 2026 · Filed Jun 17, 2026
On Jun 15, 2026, Mokari Atabak (Chief Financial Officer) sold 40,000 Corcept Therapeutics Incorporated shares at an average US$81.15 for US$3.25M under a trading plan, leaving 16,130 shares. Filed Jun 17, 2026 (Form 4).
- Sold
- 40,000 shares
- Price
- US$81.15 average (US$80.02 to US$82.45)
- Value
- US$3.25M
- Holding after
- 16,130 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | Option exercise | 40,000 | US$19.26 | 56,130 | Direct |
| Jun 15, 2026 | Common Stock | Sale | 9,434 | US$80.02 | 46,696 | Direct |
| Jun 15, 2026 | Common Stock | Sale | 11,081 | US$80.94 | 35,615 | Direct |
| Jun 15, 2026 | Common Stock | Sale | 19,483 | US$81.81 | 16,132 | Direct |
| Jun 15, 2026 | Common Stock | Sale | 2 | US$82.45 | 16,130 | Direct |
Source
Related
- Corcept Therapeutics Incorporated
- Mokari Atabak
- Corcept Therapeutics Incorporated shareholders
- Form 4 · Mokari Atabak · Sep 3, 2026
- Form 4 · Mokari Atabak · Aug 3, 2026
- Form 4 · Mokari Atabak · Jul 17, 2026
- Form 4 · Mokari Atabak · Jun 3, 2026
- Form 4 · Wilson James N · Oct 16, 2026
- Form 4 · Vieira Roberto Wandenkolk · Oct 5, 2026
- Form 4 · Maduck Sean · Oct 5, 2026
- Form 4 · Lyon Joseph Douglas · Oct 5, 2026
- Form 4 · Robb Gary Charles · Sep 28, 2026